Company: STAA
Filing Date: 2025-09-16
Form Type: DEFM14A
Source: 0001193125-25-204396
Chunk: 80

Company: STAAR SURGICAL CO
Filing Date: 2025-09-16
Form: DEFM14A
Chunk 80
---
 transaction), and a premium of approximately 59% over the volume weighted average price of STAAR common stock for the 90 days ended August 4, 2025.                                                                  |

| • |     | Cash Consideration; Certainty of Value. The Board considered the fact that the Merger Consideration is a                                                                                                                                      
 fixed cash amount, providing STAAR stockholders with certainty of value and liquidity immediately upon the closing of the Merger, in comparison to the risks, uncertainties and longer potential timeline for realizing equivalent value from 
 STAAR’s standalone business plan or possible strategic transactions involving stock consideration or alternative acquirors.                                                                                                                   |

| • |     | Value Relative to Other Strategic Alternatives. The Board’s belief that Alcon was the transaction                                                                         
 partner most likely to offer the best combination of value and certainty to STAAR stockholders. In reaching that determination, the Board considered, among other things: |

| • |     | the Board’s view, following discussions with STAAR’s management and financial advisor, that there was                                                                                                                                       
 not a likelihood that other potential acquirors would be willing and able to engage in a transaction with STAAR with a value and contractual terms and conditions more favorable to STAAR’s stockholders than those contained in the Merger 
 Agreement; and                                                                                                                                                                                                                              |

| • |     | the fact that there was no outreach from credible third parties interested in potentially acquiring STAAR in the                                                                                                                                      
 months following widespread news reports regarding a possible sale of STAAR to Alcon in July 2024, nor any outreach following the significant decline in the trading price of STAAR common stock earlier this year, except inquiries from Party A and 
 Party B shortly before the Merger Agreement was executed that did not provide any indication of proposed valuation, timing, diligence requirements, financing capability, transaction structure or other terms of a possible transaction;             |

| • |     | Terms of the Merger Agreement. The Board considered the terms and conditions of the Merger Agreement,                                                                                                
 which were reviewed by the Board, with the assistance of STAAR’s outside legal and financial advisors, and the fact that such terms were the result of robust, arm’s-length negotiations between the 
 parties. Specifically, among other things, the Board considered:                                                                                                                                     |

| • |     | the ability of STAAR to, subject to specified limitations, respond to and engage in discussions regarding                                                                                                                                            
 unsolicited third-party acquisition proposals under certain circumstances and, ultimately, to terminate the Merger Agreement in order to enter into a